ACO/ARO/AIO-21-capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer patients: a phase I trial of the German rectal cancer study group - Fleischmann, Maximilian; Diefenhardt, Markus; Nicolas, Adele M.; Rödel, Franz; Ghadimi, Michael; Hofheinz, Ralf-Dieter; Greten, Florian; Rödel, Claus; Fokas, Emmanouil (Clinical and translational radiation oncology, 2022)
Online verfügbar: 6. April 2022, Artikelversion: 10. April 2022